Institutional investors hold a majority ownership of AMGN through the 83.38% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FINANCIAL MANAGEMENT, ... Bought 1.5 Million shares of Amgen
TIAA-CREF INVESTMENT MANAGEMENT ... Bought 1.3 Million shares of Amgen
PUTNAM INVESTMENT MANAGEMENT LLC Bought 1.2 Million shares of Amgen